Connection

Daniel Duerschmied to Betacoronavirus

Back to Details
This is a "connection" page, showing publications Daniel Duerschmied has written about Betacoronavirus.
Daniel Duerschmied
Connection Strength
0.036
Betacoronavirus
  1. Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis. Crit Care. 2020 09 29; 24(1):590.
    View in: PubMed
    Score: 0.010
  2. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):470.
    View in: PubMed
    Score: 0.009
  3. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report. ASAIO J. 2020 06; 66(6):607-609.
    View in: PubMed
    Score: 0.009
  4. Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19. J Thromb Thrombolysis. 2020 Oct; 50(3):558-566.
    View in: PubMed
    Score: 0.002
  5. Pulmonary artery thrombi are co-located with opacifications in SARS-CoV2 induced ARDS. Respir Med. 2020 10; 172:106135.
    View in: PubMed
    Score: 0.002
  6. Extracorporeal cytokine adsorption as an alternative to pharmacological inhibition of IL-6 in COVID-19. Crit Care. 2020 08 20; 24(1):514.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.